(Press-News.org) New Rochelle, NY, October 17, 2025—Mary Ann Liebert, Inc., is pleased that Wai Hong (Kevin) Lo, PhD, has been appointed the new Editor-in-Chief of the journal ASSAY and Drug Development Technologies. Dr. Lo is replacing Bruce Melancon, PhD as Editor-in-Chief.
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.
“It has been an honor and a pleasure to serve as Editor-in-Chief of ASSAY and Drug Development Technologies these past few years. I am delighted to pass the baton to Dr. Lo, who I’m certain will take the journal to new heights,” said Dr. Melancon.
“My vision for ASSAY and Drug Development Technologies is to create a platform that genuinely represents diverse voices in authorship, readership, and editorial contributions, while maintaining its leadership in the field. I plan to introduce innovative approaches, such as enhancing online accessibility, incorporating visuals and lay summaries, and increasing social media engagement. These efforts will help us reach a broader audience, making our content more engaging and relevant to diverse scientific and industrial communities. I am excited to take on the role of Editor-in-Chief and lead these initiatives forward,” said Dr. Lo.
Dr. Lo is an accomplished biotechnology researcher and translational scientist with over 20 years of experience. As an Associate Professor at the University of Connecticut Health Center, his research expertise includes tissue regenerative engineering, biochemistry, cell signaling studies, biomaterials development, animal models, and drug discovery and delivery. His research programs have been continuously funded by federal agencies such as the National Institutes of Health. Dr. Lo has a remarkable editorial track record. He serves as the founding Deputy Editor of the Journal of Racial and Ethnic Health Disparities, where he played a pivotal role in establishing its prominence in the field. Additionally, he serves as an Associate Editor for PLoS ONE and Frontiers in Bioengineering and Biotechnology and is on the editorial boards of prestigious journals such as Scientific Reports, Biomedicines, and Regenerative Engineering and Translational Medicine.
Mary Ann Liebert, Inc., would like to thank Dr. Melancon for his dedication and service to the journal.
About the Journal
ASSAY and Drug Development Technologies is an international pharmaceutical science journal dedicated to the publication of innovative research, scientific reviews, and academic communications pertaining to all aspects of innovative early-stage research, techniques, and tools for optimizing new pharmaceutical development. Tables of content and a free sample issue may be viewed on the ASSAY and Drug Development Technologies website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc., publishers website.
END
Announcing the new editor-in-chief of ASSAY and Drug Development Technologies
2024-10-18
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Finding could help turn trees into affordable, greener industrial chemicals
2024-10-18
EMBARGOED FOR RELEASE UNTIL 2 P.M. EDT ON FRIDAY, OCT. 18
Trees are the most abundant natural resource living on Earth’s land masses, and North Carolina State University scientists and engineers are making headway in finding ways to use them as sustainable, environmentally benign alternatives to producing industrial chemicals from petroleum.
Lignin, a polymer that makes trees rigid and resistant to degradation, has proven problematic. Now those NC State researchers know why: They’ve identified the ...
UTA to host discussion on Texas energy needs
2024-10-18
The University of Texas at Arlington will host GridNEXT DFW 2024: Meeting the Demand, an event dedicated to envisioning the future of energy infrastructure, on Oct. 25 from 9 a.m. to 3 p.m.
The one-day seminar will bring together industry partners, leaders, government officials and private stakeholders across the Texas energy space to discuss growing power needs and how to better support the Texas power grid.
It will be held at UTA’s Rio Grande Ballroom, 300 W. First St. in Arlington. Woody Rickerson, ERCOT senior vice ...
Preventive medicine professors part of collaborative grant for AI system to enhance Alzheimer's caregiving
2024-10-18
Jennifer Martindale-Adams, EdD, and Linda Nichols, PhD, professors in the Department of Preventive Medicine in the College of Medicine at the University of Tennessee Health Science Center, are members of a team led by Xiaopeng Zhao, PhD, professor in the Department of Mechanical, Aerospace, and Biomedical Engineering at the University of Tennessee, Knoxville, that was recently awarded $401,090 grant from the National Institute on Aging for the development of the RISE project, “Robot-based Information and Support to Enhance Alzheimer’s Caregiver ...
Tropical mammals react to changes in lunar light
2024-10-18
The full moon has a bad reputation for bringing out the worst in people, from werewolves to lunatics. However, it turns out that the lunar cycle can impact behavior – at least in tropical mammals.
New research appearing in the Proceedings of the Royal Society B reveals that half of the mammal species in tropical forests adjust their behaviors in response to the moon's phases and corresponding variations in light.
By Caleb Hess, Cathrine Glosli
Michigan State University ecologist Lydia Beaudrot, who studies tropical ecology and conservation, was among the international cohort of researchers who contributed to the study. ...
Pennington Biomedical’s EAT2 study to explore unknown effects of weight fluctuations
2024-10-18
Dr. Ursula White, an associate professor of Clinical Science at Pennington Biomedical Research Center, is taking a deep dive into the lasting health effects of short-term weight gain and weight loss. The ability for the fat tissue to expand or contract to accommodate changes in body weight is important for sustained health. Dr. White’s clinical study at Pennington Biomedical, the EAT2 study, will allow her to explore how changes within the adipose tissue are affected by weight gain and weight loss, and what that means for a person’s health.
The EAT2 study is recruiting participants now, and participants will be randomly assigned ...
Butterfly brains reveal the tweaks required for cognitive innovation
2024-10-18
A species of tropical butterfly with unusually expanded brain structures display a fascinating mosaic pattern of neural expansion linked to a cognitive innovation.
The study, published today in Current Biology, investigates the neural foundations of behavioural innovation in Heliconius butterflies, the only genus known to feed on both nectar and pollen. As part of this behaviour, they demonstrate a remarkable ability to learn and remember spatial information about their food sources—skills previously connected to the expansion of a brain structure called the mushroom bodies, responsible for learning and memory.
Lead author Dr Max ...
Time to sustained recovery among outpatients with COVID-19 receiving montelukast vs placebo
2024-10-18
About The Study: In this randomized clinical trial of outpatients with mild to moderate COVID-19, treatment with montelukast did not reduce duration of COVID-19 symptoms. These findings do not support the use of montelukast for the treatment of mild to moderate COVID-19.
Corresponding Author: To contact the corresponding author, Susanna Naggie, MD, MHS, email susanna.naggie@duke.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.39332)
Editor’s Note: Please see the article for additional information, including other authors, author ...
Drones prove effective way to monitor maize re-growth, researchers report
2024-10-18
Maize, or corn, grows tall, with thin stalks that boast ears of the cereal grain used in food production, trade and security globally. However, due to rain, wind and other increasingly extreme weather events, the maize falls down, risking the entire crop. Called lodging, the physical fall results in shorter plants and overlapping leaves — both of which negatively impact the plant’s ability to grow.
Conventional lodging prevention and mitigation requires many agricultural technicians significant time to investigate the crop fields, according to a team of researchers based in China. They ...
Materials of the future can be extracted from wastewater
2024-10-18
"The perspective is enormous, because you’re taking something that is currently waste and making high-value products from it."
This is what Professor Per Halkjær Nielsen, Department of Chemistry and Bioscience at Aalborg University in Denmark, says about the results of a research project that utilizes surplus biomass in wastewater treatment plants in new ways. The focal point is biopolymers that can be described as long chains of molecules that are bound to each other and that are produced by living organisms, including bacteria. Today, synthetic ...
Long-lasting immunotherapy response in stage IV lung cancer with brain metastasis
2024-10-18
“In the last decade, immunotherapy agents changed the treatment landscape for Non-Small Cell Lung Cancer (NSCLC).”
BUFFALO, NY - October 18, 2024 – A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, “Complete and long-lasting response to immunotherapy in a stage IV non-small cell lung cancer with brain metastasis.”
As highlighted in the abstract of this report, approximately 20% of lung cancer patients have brain metastases at diagnosis, which is associated with a worse prognosis and negatively impacts quality ...